Oncology
肿瘤科 · Jiangxi Provincial People's Hospital, Nanchang
Established in the 1990s, this department provides comprehensive cancer care, including radiotherapy, chemotherapy, and targeted therapy. It treats various malignancies such as lung, breast, liver, and nasopharyngeal cancers. The team uses advanced equipment, including a Swedish Elekta digital linear accelerator and three-dimensional treatment planning systems, to ensure precise tumor targeting. Therapies include individualized chemotherapy plans using automated infusion pumps and high-intensity focused ultrasound (HIFU) for eligible patients. The department aims to improve treatment efficacy and long-term survival rates through standardized, combined modality approaches. It serves as a national institution for oncology drug trials and trains medical professionals.
Conditions and treatments
- Radiotherapy using Elekta digital linear accelerators
- Individualized chemotherapy with automated infusion pumps
- Targeted therapy for lung, breast, colorectal cancer, and lymphoma
- High-intensity focused ultrasound (HIFU) treatment
- Treatment of brain, nasopharyngeal, liver, and prostate cancers
- Comprehensive management of malignant lymphoma
Key facts
- The department was founded in the 1990s and has over 100 beds across two wards.
- The staff includes 56 medical and technical personnel, with 10 holding senior titles.
- It was approved as a national oncology drug trial institution by the Ministry of Health in 2004.
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Specialty | Medical Oncology |
|---|---|
| Doctors listed | 12 |
| Chief physicians | — |
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us